Medical/Pharmaceuticals

RedHill Biopharma Announces Two New U.S. Patents Covering Opaganib for Ebola Virus and RHB-104 for Crohn's

U.S. patents for opaganib combination for the treatment of Ebola virus disease provides patent protection until 2035 Opaganib's 475-patient global Phase 2/3 study in severe COVID-19 approaching completion with upcoming top-line results Opaganib also undergoing two oncology Phase 2 U.S. studies a...

2021-08-23 19:00 3686

Concord Medical Completes RMB 400 Million Funding Round Led by Consortium Investors

BEIJING, Aug. 23, 2021 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specializes in cancer treatment, research, education, and prevention by establishing proton centers and specialty cancer hospitals and operating...

2021-08-23 18:10 4303

Everest Medicines to Announce Half-Year 2021 Interim Results

SHANGHAI, Aug. 23, 2021 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients inGreater China and other parts of Asia, today announced t...

2021-08-23 15:20 2920

NeuExcell Therapeutics names Russ Addis as Vice President, Research

STATE COLLEGE, Penn., Aug. 23, 2021 /PRNewswire/ -- NeuExcell Therapeutics Inc. (www.neuexcell.com) today announced the appointment of Russ Addis, Ph.D. to the new position of Vice President, Research, effective immediately. Dr. Addis will report directly to Dr. Ronald HW Lorijn, Chief Executive ...

2021-08-23 13:00 1493

Menarini Enters into an Exclusive Licensing Agreement with Daiichi Sankyo to Commercialise TARLIGE(R) in Singapore, Malaysia, and the Philippines

SINGAPORE, Aug. 23, 2021 /PRNewswire/ -- A. Menarini Asia-Pacific Holdings Pte. Ltd., part of the leading Italian global biopharmaceutical company Menarini Group, signed a multi-year exclusive licensing agreement to assume the registration, sales, marketing, and distribution of the orally adminis...

2021-08-23 09:00 1768

Inclusion of Kintor as a Constituent Stock of HSCI

SUZHOU, China, Aug. 23, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, announced today that the company's stock has been included in the Hang Seng Composite ...

2021-08-23 08:44 2523

Ocumension Therapeutics Announces 2021 Interim Results

Company loss narrowed sharply by 96% Business Income Increased By More Than 26 Times Year-on-Year Core Product OT-401 Approval Imminent HONG KONG, Aug. 21, 2021 /PRNewswire/ -- The Chinese ophthalmology platform company,Ocumension Therapeutics ("Ocumension" or the "Company", together with its s...

2021-08-21 00:19 16407

Roche and KeChow Reach a Cooperation Agreement

SHANGHAI, Aug. 20, 2021 /PRNewswire/ -- On August 2, 2021, Shanghai Roche Pharmaceuticals Co., Ltd. (hereinafter referred to as "Roche Pharma China" or "Roche") and Shanghai KeChow Pharma, Inc. (hereinafter referred to as "KeChow Pharma" or "KeChow") entered into a cooperation agreement to improv...

2021-08-20 23:00 2754

Insilico Medicine Collaborates with BioNova to Develop Small Molecule Drugs for Hematologic Malignancies

SHANGHAI, Aug. 20, 2021 /PRNewswire/ -- Insilico Medicine ("Insilico"), an end-to-end artificial intelligence-driven drug discovery company, and BioNova Pharmaceuticals (Shanghai) Ltd. ("BioNova"), a clinical-stage biopharmaceutical company, today announced entry into a collaboration agreement to...

2021-08-20 21:12 4185

Argon Medical Devices, Inc. Announces the Commercial Launch of the SKATER™ Mini-Loop Drainage Catheter

FRISCO, Texas, Aug. 20, 2021 /PRNewswire/ -- Argon Medical Devices, Inc., a leading manufacturer of medical devices for interventional procedures, announced the commercial launch of SKATER™ Mini-Loop Drainage Catheters inthe United States and the European Union. The SKATER™ Mini-Loop is a drain...

2021-08-20 21:00 3218

CStone Pharmaceuticals Selected as a Constituent of HSCI

SUZHOU, China, Aug. 20, 2021 /PRNewswire/ -- CStone Pharmaceuticals (HKEX: 2616, "CStone" or the "Company"), a leading biopharmaceutical company focused on researching, developing, and commercializing innovative immuno-oncology therapies and precision medicines, announced that the Company has bee...

2021-08-20 20:24 5232

Bupa Global launches Private Client, a first in market service redefining premium healthcare with dedicated Lifecare Concierge

Research reveals a rising interest in personalised and preventative healthcare amongst high net-worth individuals * Insights show there is continued impact from the pandemic, with 80% of HK top executives/ HNWIs having experienced mental health symptoms over the past year, with the most common...

2021-08-20 16:18 2148

Standigm Expands Global Footprints with New Office in Cambridge, UK

SEOUL, South Korea, Aug. 20, 2021 /PRNewswire/ -- Standigm, a leading workflow AI drug discovery company, today announced the opening of a new office in Cambridge, United Kingdom ("UK"), to accommodate the company's rapid growth in the European market. Founded in 2015, Standigm has proprietary ...

2021-08-20 15:30 1214

Neurophth Expands Its Global Gene Therapy Leadership Team with the Appointment of Dr. Zhengbin Li as Head of Commercial

WUHAN, China and SAN DIEGO, Aug. 19, 2021 /PRNewswire/ -- Neurophth Biotechnology Ltd., a fully-integrated genomic medicines company committed to the development of AAV-delivered gene therapies for the treatment of ocular diseases, today announced the recent appointment of Dr. Zhengbin (Luke) Li ...

2021-08-19 22:00 1485

RapidAI Achieves Record Momentum Amid Demand for Improved Clinical Decision Making and Patient Workflow

SAN MATEO, Calif., Aug. 19, 2021 /PRNewswire/ -- RapidAI, the global leader in neurovascular and vascular imaging driving the next evolution of clinical decision making and patient workflow, today announced record corporate momentum with more than2.8M scans to date on its platform — the most clin...

2021-08-19 22:00 1632

Daewoong Pharmaceutical and Hanall Biopharma Invest $1M USD in Alloplex Biotherapeutics

SEOUL, South Korea, Aug. 19, 2021 /PRNewswire/ -- Daewoong Pharmaceutical and Hanall Biopharma ofSouth Korea are expanding their global open collaboration initiative by investing in Alloplex Biotherapeutics, an emergingBoston-based biotechnology company.

2021-08-19 21:00 1652

Shielding Our Singapore Spirit: Mamoru Marketing Shields More Than 12,000 NDP 2021 Participants with Clinical Grade ECOM products

SINGAPORE, Aug. 19, 2021 /PRNewswire/ -- Celebrating Singapore's 56th year of independence, Mamoru Marketing Pte Ltd, exclusive distributor for ECOM products inSingapore, is proud to partner with the National Day Parade (NDP) 2021 for the first time this year to lend a hand in ensuring a COVID-Sa...

2021-08-19 20:47 2872

Speclipse attracts $7.7M in investments with its laser spectroscopic and artificial intelligence medical diagnosis technology

SEOUL, South Korea, Aug. 19, 2021 /PRNewswire/ -- Speclipse, a startup specializing in laser spectroscopic and AI-based medical diagnosis technologies and a member ofBorn2Global Centre, recently attracted USD 7.7 million in investments for an accumulated investment total ofUSD 13 million. ...

2021-08-19 20:30 1345

PharmAbcine Announces Submission of PCT for an Anti-ANG2 Antibody for the Treatment of Ocular Diseases

DAEJEON, South Korea, Aug. 19, 2021 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of next-generation antibody therapeutics, today announced it submitted a Patent Cooperation Treaty (PCT), an international patent application, for ...

2021-08-19 20:00 1074

I-Mab Announces Establishment of Environmental, Social and Governance Committee

* I-Mab received highest first-time ESG rating among China-based biotech companies from MSCI * New majority independent ESG committee to set overall ESG strategies for the Company * Women account for two-thirds of the total workforce and over 30% of I-Mab's Board of Directors * Committed ...

2021-08-19 19:00 3412
1 ... 349350351352353354355 ... 576